Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 41.35 Billion | USD 84.36 Billion | 8.3% | 2024 |
FrequentlyAsked Questions
The global ophthalmic drugs market is expected to grow due to rising prevalence of eye disorders, increasing geriatric population, and growing investments in novel ophthalmic treatment solutions.
According to a study, the global ophthalmic drugs market size was worth around USD 41.35 Billion in 2024 and is expected to reach USD 84.36 Billion by 2034.
The global ophthalmic drugs market is expected to grow at a CAGR of 8.3% during the forecast period.
North America is expected to dominate the ophthalmic drugs market over the forecast period.
Leading players in the global ophthalmic drugs market include NOVARTIS AG, F. HOFFMANN-LA ROCHE LTD, BAUSCH & LOMB INCORPORATED, Alcon Inc., ABBVIE Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD., SUN PHARMACEUTICAL INDUSTRIES LIMITED, SANTEN PHARMACEUTICAL CO. LTD, REGENERON PHARMACEUTICALS INC., PFIZER INC, among others.
The report explores crucial aspects of the ophthalmic drugs market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed